Cutaneous Ewing Sarcoma Presenting as a Second Primary Malignancy in a Child

J Pediatr Hematol Oncol. 2022 Nov 1;44(8):486-488. doi: 10.1097/MPH.0000000000002457. Epub 2022 Apr 14.

Abstract

Ewing sarcoma is an EWS-ETS family member-driven malignancy that most commonly arises from bone. Cutaneous Ewing sarcoma is a rare variant which harbors an EWS-ETS family fusion but demonstrates an immunohistochemical staining pattern distinct from classic Ewing tumors. EWSR1 fluorescence in situ hybridization testing interpretation can be challenging in the setting of cutaneous Ewing sarcoma, making an integrated histologic and sequencing approach key for an accurate diagnosis. Here, we report a pediatric patient with a history of neuroblastoma treated with surgery only that developed a cutaneous nodule and was diagnosed with cutaneous Ewing sarcoma as a second primary cancer.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Neoplasms* / diagnosis
  • Bone Neoplasms* / genetics
  • Bone Neoplasms* / pathology
  • Child
  • Family
  • Humans
  • In Situ Hybridization, Fluorescence
  • Neoplasms, Second Primary* / diagnosis
  • Neoplasms, Second Primary* / genetics
  • Oncogene Proteins, Fusion / genetics
  • RNA-Binding Protein EWS / genetics
  • Sarcoma, Ewing* / diagnosis
  • Sarcoma, Ewing* / genetics
  • Sarcoma, Ewing* / pathology

Substances

  • Oncogene Proteins, Fusion
  • RNA-Binding Protein EWS